AS
UTHR icon

Altshuler Shaham’s United Therapeutics UTHR Stock Holding History

Altshuler Shaham’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.33K Buy
+8
New +$4.5K ﹤0.01% 405
2023
Q2 		– Sell
-136
Closed -$30.5K – 404
2023
Q1 		$30.5K Sell
136
-83
-38% -$20.5K ﹤0.01% 269
2022
Q4 		$60.9K Sell
219
-52
-19% -$13.1K ﹤0.01% 183
2022
Q3 		$56K Sell
271
-27
-9% -$6.04K ﹤0.01% 206
2022
Q2 		$70K Buy
298
+77
+35% +$15.7K ﹤0.01% 194
2022
Q1 		$40K Buy
+221
New +$42.1K ﹤0.01% 417
2021
Q3 		– Sell
-623
Closed -$112K – 666
2021
Q2 		$112K Buy
623
+5
+0.8% +$952 ﹤0.01% 312
2021
Q1 		$103K Buy
618
+338
+121% +$56.4K ﹤0.01% 218
2020
Q4 		$43K Buy
280
+36
+15% +$4.72K ﹤0.01% 281
2020
Q3 		$25K Sell
244
-157
-39% -$17.2K ﹤0.01% 310
2020
Q2 		$49K Buy
401
+101
+34% +$11.4K ﹤0.01% 195
2020
Q1 		$28K Buy
+300
New +$28.5K ﹤0.01% 212

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Altshuler Shaham's UTHR Position: Q2 2026 in Review

Altshuler Shaham opened a new position in United Therapeutics (UTHR) in Q2 2026: 8 shares worth $4.33K. The stake represents ﹤0.01% of the portfolio and ranks #405 among its holdings. This is a return to the name: Altshuler Shaham previously reported a position in UTHR as recently as Q1 2023.

Altshuler Shaham first reported a position in UTHR in Q1 2020 and has held it in 12 quarters since. The position peaked at $112K in Q2 2021. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Altshuler Shaham held 8 shares of United Therapeutics worth $4.33K as of Q2 2026.
  • United Therapeutics was a new Altshuler Shaham position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Altshuler Shaham's portfolio in Q2 2026, its #405 holding.
  • Altshuler Shaham first reported a position in United Therapeutics in Q1 2020 and has held it in 12 quarters since.
  • Altshuler Shaham's United Therapeutics position peaked at $112K in Q2 2021.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Altshuler Shaham's 13F filing for Q2 2026, filed 12 Aug 2026.